Genedrive plc
Company Profile
Genedrive plc is a molecular diagnostics company developing and
commercialising a low cost, rapid, versatile, simple to use and
robust point of need molecular diagnostics platform for the
diagnosis of infectious diseases and for use in patient
stratification (genotyping), pathogen detection and other
indications.
The Company has assays on the market for the detection of MT-RNR1,
HCV, certain military biological targets, a high throughput
SARS-CoV-2 assay and a point of care test for Covid-19.
The company are currently developing a genetic test for CYP2C19 metaboliser status.
Latest Company Summary
Investor Access
Management will hold the company’s AGM on Monday, 30 December 2024
The Company’s 2024 Annual Report and Accounts are now available on the Company's website http://www.genedriveplc.com/investor-relations/company-reports.phpMonday, 30 December 2024 at 10am
| Event | Date |
| Year End | 30 June |
| Half Year End | 31 December |
| Preliminary Results | November |
| Interim Results* | March |
| AGM* | December |
* Months based on previous announcements of this kind
